Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Aug 7, 2023; 29(29): 4580-4592
Published online Aug 7, 2023. doi: 10.3748/wjg.v29.i29.4580
Table 3 Multivariate analysis of risk factors for osteoporosis in overall and women patients with primary biliary cholangitis
VariablesOverall patients (n = 268)
Overall patients underwent liver biopsy (n = 163)
Women patients (n = 236)
Women patients underwent liver biopsy (n = 150)
OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
Age, per 10 years1.80 (1.33-2.44)< 0.0011.95 (1.30-2.92)0.0011.63 (1.04-2.57)0.0352.02 (1.27-3.20)0.003
FatigueNSNSNSNS
SplenomegalyNSNS2.62 (1.18-5.80)0.018NS
Gastroesophageal varices2.11 (1.14-3.92)0.018NSNSNS
AscitesNSNSNSNS
BMI0.85 (0.77-0.93)< 0.0010.87 (0.77-0.98)0.0230.83 (0.75-0.92)< 0.0010.85 (0.74-0.97)0.014
Previous steroid use4.19 (1.66-10.56)0.002NS4.01 (1.42-11.31)0.0093.99 (1.24-12.87)0.020
Mayo risk score1.36 (1.08-1.71)0.009NS1.61 (1.22-2.14)0.0011.64 (1.12-2.41)0.011
ALTNSNSNSNS
BilirubinNS1.20 (1.01-1.42)0.044NSNS
AlbuminNSNSNSNS
PTANSNSNSNS
PLTNSNSNSNS
Postmenopausal2.92 (1.02-8.38)0.046NS
Histological stage Ⅲ or Ⅳ3.74 (1.60-8.77)0.0023.02 (1.13-8.06)0.027